Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 01:04:35 2026-04-10 pm EDT			5-day change	1st Jan Change
189.96 ^USD	-1.57%		-0.91%	-16.84%

Apr. 08	Wolfe Research Adjusts Price Target on Danaher to $230 From $260, Maintains Outperform Rating	MT
Apr. 08	Jefferies Adjusts Price Target on Danaher to $240 From $265, Maintains Buy Rating	MT

Danaher Corporation Announces Quarterly Dividend, Payable on April 24, 2026

Published on 02/24/2026 at 04:30 pm EST

S&P Capital IQ

DANAHER CORPORATION

-1.57%

Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026 to holders of record on March 27, 2026.

Latest news about Danaher Corporation

Apr. 08	Wolfe Research Adjusts Price Target on Danaher to $230 From $260, Maintains Outperform Rating	MT
Apr. 08	Jefferies Adjusts Price Target on Danaher to $240 From $265, Maintains Buy Rating	MT
Apr. 07	Azenta, Inc. Announces Executive Changes	CI
Apr. 06	Evercore ISI Adjusts Danaher Price Target to $225 From $254, Maintains Outperform Rating	MT
Apr. 02	AstroNova, Inc. Announces Management Appointments in Product Identification Segment	CI
Apr. 02	ESAB Corporation Announces Chief Financial Officer Changes	CI
Apr. 02	ESAB Corporation Announces Executive Changes	CI
Mar. 19	Apple avoids new import ban on Apple Watch
Mar. 17	NOV Inc. Appoints Sanjay Chowbey to the Board of Directors, Effective March 17, 2026	CI
Mar. 17	Altai Capital presses OraSure to sell and give it board seats, letter says	RE
Mar. 09	RBC Sees Sartorius Stedim Biotech Share Weakness as 'Entry Point'; Rating, Price Target Revised	MT
Mar. 09	Agilent to acquire Biocare Medical in $950 million all-cash deal	RE
Mar. 04	DorsaVi Ltd Establishes Technical Advisory Board	CI
Mar. 03	Danaher Corporation Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 01:50 PM
Feb. 26	Quest Diagnostics Announces Appointment of Benjamin Beauvalot as Senior Vice President, Chief Strategy and M&A Officer	CI

Chart Danaher Corporation

Duration

Period

DHR: Dynamic Chart

Company Profile

Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).

Employees

59,000

Sector

Advanced Medical Equipment & Technology

Calendar

Apr. 21 - Earnings release - Q1 2026

More about the company